DNA methylation in neonates born to women receiving psychiatric care

Epigenetics

Volumn 7, Issue 4, 2012, Pages 409-414

  Schroeder, James W ^a   Smith, Alicia K ^a,b   Brennan, Patricia A ^a   Conneely, Karen N ^b   Kilaru, Varun ^b   Knight, Bettina T ^b   Newport, D Jeffrey ^b   Cubells, Joseph F ^b   Stowe, Zachary N ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Depressive symptoms; DNA methylation; Humanmethylation27 beadchip; Infinium; Prenatal exposures

Indexed keywords

AMFEBUTAMONE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA2; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY 21; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CPG ISLAND; DNA METHYLATION; FEMALE; FETUS DEVELOPMENT; HUMAN; HUMAN GENOME; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; NEWBORN; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PROGENY; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; UMBILICAL CORD BLOOD;

EID: 84860545186     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.19551     Document Type: Article

References (51)

1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103:698-709; PMID:15051562; http://dx.doi.org/10.1097/01. AOG.0000116689.75396.5f.
2. Beydoun H, Saftlas AF. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol 2008; 22:438-66; PMID:18782252; http:// dx.doi.org/10.1111/j.1365-3016.2008.00951.x.
3. Wadhwa PD, Culhane JF, Rauh V, Barve SS, Hogan V, Sandman CA, et al. Stress, infection and preterm birth: a biobehavioural perspective. Paediatr Perinat Epidemiol 2001; 15:17-29; PMID:11520397; http:// dx.doi.org/10.1046/j.1365-3016.2001.00005.x.
4. Field T, Diego M, Hernandez-Reif M, Schanberg S, Kuhn C, Yando R, et al. Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. Depress Anxiety 2003; 17:140-51; PMID:12768648; http://dx.doi.org/10.1002/ da.10071.
5. Brazelton TB. Assessment of the infant at risk. Clin Obstet Gynecol 1973; 16:361-75; PMID:4575534; http://dx.doi.org/10.1097/00003081-197303000-00020.
6. Jones NA, Field T, Fox NA, Davalos M, Lundy B, Hart S. Newborns of depressed mothers are physiologically less developed. Infant Behav Dev 1998; 21:537-41; http://dx.doi.org/10.1016/S0163-6383(98)90027-3.
7. Zuckerman B, Bauchner H, Parker S, Cabral H. Maternal depressive symptoms during pregnancy and newborn irritability. J Dev Behav Pediatr 1990; 11:190-4; PMID:2212032; http://dx.doi. org/10.1097/00004703-199008000-00006.
8. Silberg JL, Maes H, Eaves LJ. Genetic and environmental influences on the transmission of parental depression to children's depression and conduct disturbance: an extended Children of Twins study. J Child Psychol Psychiatry 2010; 51:734-44; PMID:20163497; http:// dx.doi.org/10.1111/j.1469-7610.2010.02205.x.
9. Hay DF, Pawlby S, Waters CS, Perra O, Sharp D. Mothers' antenatal depression and their children's antisocial outcomes. Child Dev 2010; 81:149-65; PMID:20331659; http://dx.doi.org/10.1111/j.1467-8624.2009.01386.x.
10. Gerardin P, Wendland J, Bodeau N, Galin A, Bialobos S, Tordjman S, et al. Depression during pregnancy: is the developmental impact earlier in boys? A prospective case-control study. J Clin Psychiatry 2011; 72:378-87; PMID:21208585; http://dx.doi.org/10.4088/ JCP.09m05724blu.
11. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198:194; PMID:17905176; http:// dx.doi.org/10.1016/j.ajog.2007.07.036.
12. Cohen LS, Nonacs RM, Bailey JW, Viguera AC, Reminick AM, Altshuler LL, et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Womens Ment Health 2004; 7:217-21; PMID:15338315; http://dx.doi.org/10.1007/s00737-004-0059-3.
13. Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 2011; 72:979-85; PMID:21457681; http://dx.doi. org/10.4088/JCP.10m06090blu.
14. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 2000; 48:1032-4; PMID:11082480; http://dx.doi.org/10.1016/S0006-3223(00)00958-6.
15. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-6; PMID:12727706; http://dx.doi.org/10.1176/appi. ajp.160.5.993.
16. Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007; 16:474-84; PMID:16897811; http:// dx.doi.org/10.1002/pds.1296.
17. Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatr 2010; 31:641-8; PMID:20613624; http://dx.doi.org/10.1097/ DBP.0b013e3181e5ac93.
18. Galbally M, Lewis AJ, Buist A. Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry 2011; 45:393-9; PMID:21314237; http://dx.doi.org/10.3109/0004867 4.2010.549995.
19. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402-8; PMID:12712058; http://dx.doi. org/10.1067/mpd.2003.139.
20. Lorenzo L, Byers B, Einarson A. Antidepressant use in pregnancy. Expert Opin Drug Saf 2011; 10:883-9; PMID:21545242; http://dx.doi.org/10.1517/1474033 8.2011.583917.
21. Henry AL, Beach AJ, Stowe ZN, Newport DJ. The fetus and maternal depression: implications for antenatal treatment guidelines. Clin Obstet Gynecol 2004; 47:535-46; PMID:15326416; http://dx.doi. org/10.1097/01.grf.0000135341.48747.f9.
22. Zhang TY, Meaney MJ. Epigenetics and the environmental regulation of the genome and its function. Annu Rev Psychol 2010; 61:439-66; PMID:19958180; http://dx.doi.org/10.1146/annurev. psych.60.110707.163625.
23. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008; 3:97-106; PMID:18536531; http://dx.doi.org/10.4161/ epi.3.2.6034.
24. Devlin AM, Brain U, Austin J, Oberlander TF. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One 2010; 5:12201; PMID:20808944; http://dx.doi.org/10.1371/journal.pone.0012201.
25. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, et al. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 1998; 431:351-6; PMID:9714541; http://dx.doi.org/10.1016/S0014-5793(98)00791-1.
26. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009; 457:981-9; PMID:19225519; http://dx.doi.org/10.1038/nature07767.
27. Zhao H, Yan M, Wang H, Erickson S, Grewal IS, Dixit VM. Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6-deficient mice. J Exp Med 2001; 194:1441-8; PMID:11714751; http://dx.doi.org/10.1084/jem.194.10.1441.
28. Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, et al. Enhanced B cell expansion, survival and humoral responses by targeting death receptor 6. J Exp Med 2003; 197:51-62; PMID:12515813; http://dx.doi.org/10.1084/jem.20020617.
29. Nicholson DW. Neuroscience: Good and bad cell death. Nature 2009; 457:970-1; PMID:19225511; http://dx.doi.org/10.1038/457970a.
30. Chambers RA, Potenza MN, Hoffman RE, Miranker W. Simulated apoptosis/neurogenesis regulates learning and memory capabilities of adaptive neural networks. Neuropsychopharmacology 2004; 29:747-58; PMID:14702022; http://dx.doi.org/10.1038/sj.npp.1300358.
31. Carvalho JR, Filipe L, Costa VL, Ribeiro FR, Martins AT, Teixeira MR, et al. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer. Apoptosis 2010; 15:956-65; PMID:20464497; http://dx.doi.org/10.1007/s10495-010-0508-6.
32. Bonati MT, Combi R, Asselta R, Duga S, Malcovati M, Oldani A, et al. Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families. J Neurol 2002; 249:967-74; PMID:12195439; http://dx.doi.org/10.1007/s00415-002-0763-8.
33. Philibert RA, Todorov A, Andersen A, Hollenbeck N, Gunter T, Heath A, et al. Examination of the nicotine dependence (NICSNP) consortium findings in the Iowa adoption studies population. Nicotine Tob Res 2009; 11:286-92; PMID:19307444; http://dx.doi.org/10.1093/ntr/ntn034.
34. Rigbi A, Kanyas K, Yakir A, Greenbaum L, Pollak Y, Ben-Asher E, et al. Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav 2008; 7:164-72; PMID:17559419; http://dx.doi.org/10.1111/j.1601-183X.2007.00329.x.
35. Tabarés-Seisdedos R, Rubenstein JL. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol Psychiatry 2009; 14:563-89; PMID:19204725; http://dx.doi.org/10.1038/mp.2009.2.
36. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet 2011; 20:4786-96; PMID:21908516; http://dx.doi.org/10.1093/hmg/ddr416.
37. Capello CF, Bourke CH, Ritchie JC, Stowe ZN, Newport DJ, Nemeroff A, et al. Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk. J Pharmacol Exp Ther 2011; 339:275-85; PMID:21775476; http://dx.doi. org/10.1124/jpet.111.183855.
38. Smith AK, Jeffrey Newport D, Ashe MP, Brennan PA, Laprairie JL, Calamaras M, et al. Predictors of Neonatal Hypothalamic-Pituitary-Adrenal Axis Activity at Delivery. Clin Endocrinol (Oxf) 2011; PMID:21521269; http://dx.doi.org/10.1111/j.1365-2265.2011.03998.x.
39. First MB, Spitzer RL MG. Structured Clinical Interview for DSM-IV-TR Axis I disorders, Research Version, Patient Edition (SCID-I/P). New York: New York State Psychiatric Institute 2002.
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62; PMID:14399272; http://dx.doi.org/10.1136/jnnp.23.1.56.
41. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-71; PMID:13688369; http:// dx.doi.org/10.1001/archpsyc.1961.01710120031004.
42. Terry P, Katz JL. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology (Berl) 1997; 134:201-12; PMID:9399385; http://dx.doi.org/10.1007/s002130050443.
43. Learned-Coughlin SM, Bergström M, Savitcheva I, Ascher J, Schmith VD, Långstrom B. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 2003; 54:800-5; PMID:14550679; http://dx.doi.org/10.1016/S0006-3223(02)01834-6.
44. Schroeder JW, Conneely KN, Cubells JC, Kilaru V, Newport DJ, Knight BT, et al. Neonatal DNA methylation patterns associate with gestational age. Epigenetics 2011; 6:1498-504; PMID:22139580; http://dx.doi.org/10.4161/epi.6.12.18296.
45. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, et al. Genome-wide DNA methylation profiling using Infinium(®) assay. Epigenomics 2009; 1:177-200; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14.
46. Bock C, Tomazou EM, Brinkman AB, Müller F, Simmer F, Gu H, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010; 28:1106-14; PMID:20852634; http://dx.doi.org/10.1038/nbt.1681.
47. Adkins RM, Krushkal J, Tylavsky FA, Thomas F. Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res A Clin Mol Teratol 2011; 91:728-36; PMID:21308978; http://dx.doi.org/10.1002/bdra.20770.
48. Liu J, Hutchison K, Perrone-Bizzozero N, Morgan M, Sui J, Calhoun V. Identification of genetic and epigenetic marks involved in population structure. PLoS One 2010; 5:13209; PMID:20949057; http://dx.doi.org/10.1371/journal.pone.0013209.
49. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5:1000602; PMID:19680444; http://dx.doi.org/10.1371/journal.pgen.1000602.
50. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008; 299:2877-83; PMID:18577732; http://dx.doi.org/10.1001/jama.299.24.2877.
51. Storey J. A direct approach to false discovery rates. J R Stat Soc 2002; 64:479-98; http://dx.doi.org/10.1111/1467-9868.00346.